ORAL RIFAMYCIN SV COMPOSITIONS
    2.
    发明申请

    公开(公告)号:WO2019092614A1

    公开(公告)日:2019-05-16

    申请号:PCT/IB2018/058748

    申请日:2018-11-07

    Abstract: Oral pharmaceutical compositions containing rifamycin SV, or a pharmaceutically salt thereof, characterized in that they are formulated in a higher strength (about 600 mg/tablet) and in such a manner to obtain a modified profile of the rifamycin SV, or a pharmaceutically acceptable salt thereof, in the proximal portion of the intestine, i.e. in the small intestine (duodenum, jejunum and ileum). In one embodiment, the disclosed oral pharmaceutical compositions are used in the prevention and/or treatment in a subject of small intestine bacterial overgrowth (SIBO) and/or irritable bowel syndrome (IBS) and/or in the treatment of cholera. In one embodiment, the disclosed oral pharmaceutical compositions are used in the prevention and/or treatment in a subject of hepatic encephalopathy, hepatic cirrhosis, pouchitis and/or spontaneous bacterial perotinitis. In one embodiment, the disclosed oral pharmaceutical compositions are used in the prevention and/or treatment in a subject of non- alcoholic fatty liver disease, non-alcoholic fatty liver or non-alcoholic steatohepatitis.

    EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND/OR ENDOSCOPIC SUBMUCOSAL DISSECTION.
    4.
    发明申请
    EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND/OR ENDOSCOPIC SUBMUCOSAL DISSECTION. 审中-公开
    乳腺或微乳液用于内镜下粘膜下腔镜检查和/或内镜下子宫切除术。

    公开(公告)号:WO2015075015A1

    公开(公告)日:2015-05-28

    申请号:PCT/EP2014/074858

    申请日:2014-11-18

    Abstract: The invention provides a pharmaceutical composition in form of emulsion or microemulsion for use in an endoscopic procedure, preferably said endoscopic procedure comprising the administration of said pharmaceutical composition to a human with the aim of improving and facilitating the resection of the lesion by raising the area where the lesion is located. The invention herein disclosed provides a method for performing an endoscopic procedure, said method preferably comprising the administration of a pharmaceutical composition in form of emulsion or microemulsion to a human. The invention herein disclosed also provides a kit for use in an endoscopic procedure, said kit comprising a pharmaceutical composition in form of emulsion or microemulsion, an endoscopic injection needle, a syringe and instructions for use thereof.

    Abstract translation: 本发明提供了用于内窥镜手术的乳剂或微乳液形式的药物组合物,优选所述内窥镜手术包括向人施用所述药物组合物,目的是通过提高所述病变的面积来改善和促进切除 病变位于。 本文公开的本发明提供了一种用于进行内窥镜手术的方法,所述方法优选包括向人类施用乳状液或微乳液形式的药物组合物。 本文公开的本发明还提供了用于内窥镜程序的试剂盒,所述试剂盒包含乳剂或微乳液形式的药物组合物,内窥镜注射针,注射器和使用说明书。

Patent Agency Ranking